–
Статьи в журналах
-
- 2023 A phase 1b study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with pretreated advanced gastric cancer
- Tsimafeyeu Ilya, Statsenko Galina, Vladimirova Liubov, Besova Natalia, Artamonova Elena, Raskin Grigory, Rykov Ivan, Mochalova Anastasia, Utyashev Igor, Gorbacheva Svetlana, Kazey Vasily, Gavrilova Evgenia, Dragun Nadezhda, Moiseyenko Vladimir, Tjulandin Sergei
- в журнале Investigational New Drugs, издательство Springer Nature (Switzerland), том 41, № 2, с. 324-332 DOI
Тезисы докладов
-
- 2022 Pharmacokinetics of alofanib and biomarker analysis in patients with advanced gastric cancer: A phase 1b study
- Raskin Grigory, Kazey Vasily, Gorbacheva Svetlana, Nikiforova Aiyyna, Statsenko Galina, Artamonova Elena, Vladimirova Liubov, Besova Natalia, Mochalova Anastasia, Rykov Ivan, Moiseyenko Vladimir, Utyashev Igor, Iugai Sergei, Dragun Nadezhda, Reznikov Dmitry, Gavrilova Evgenia, Tjulandin Sergei, Tsimafeyeu Ilya
- в сборнике Proceedings of the American Association for Cancer Research Annual Meeting 2022;, серия suppl 12, место издания Philadelphia (PA):, том 82, тезисы, с. 3481